Ambrx
Douglas Pierce has extensive work experience in financial reporting and accounting. Douglas has held roles such as VP and Controller, Director of Accounting and Financial Reporting, and Senior Manager of Financial Reporting and Consolidations in companies like Ambrx, Ostendo Technologies, and Liberty Global. With over 20 years of experience, their expertise includes SEC reporting, technical accounting, and financial consolidations.
Douglas Pierce earned a Bachelor of Science degree in Accountancy from Northern Illinois University in 1993. Douglas further obtained a CPA certification from the Colorado Board of Accountancy in 1998.
Ambrx
Ambrx, Inc. is a biopharmaceutical company with a mission to deliver breakthrough protein therapeutics. Ambrx is based on a fundamental advance in protein biosynthesis that enables the company to genetically engineer proteins with new amino acid building blocks beyond the common twenty, enabling the biosynthesis of proteins with new physical, chemical and pharmacological properties.